文献速递眼底病与葡萄膜炎

Emixustat降低视网膜暗活动中代谢需求

Emixustat Reduces Metabolic Demand of Dark Activity in the Retina.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2019-01-01

本研究在大鼠中采用锰增强磁共振成像测量阳离子内流、并记录视网膜氧分布,评估视觉周期调节剂Emixustat在暗条件下对氧消耗和阳离子内流的影响。结果显示Emixustat降低暗条件下阳离子通道活性、阻止光漂白后氧张力下降,作者认为视觉周期调节剂是缺血性视网膜新生血管化的有前景的潜在治疗。

要点

  • Emixustat降低暗条件下大鼠视网膜阳离子通道活性,其水平与光照条件下相当。
  • Emixustat阻止光漂白后视网膜最低氧张力下降,减少暗条件相关的氧消耗。
  • 作者认为视觉周期调节剂是缺血性视网膜新生血管化(如糖尿病视网膜病变)有前景的潜在治疗。

核心结论

  • Emixustat降低暗条件相关的阳离子内流和视网膜氧消耗。
  • 视觉周期调节剂是缺血性视网膜新生血管化(如糖尿病视网膜病变)有前景的潜在治疗。

研究设计与样本

  • 大鼠实验研究,采用锰增强磁共振成像(MEMRI)测量阳离子内流、记录视网膜氧分布评估氧消耗。
  • MEMRI方案中动物接受Emixustat或溶媒处理;氧分布方案中动物未处理或接受Emixustat处理。

主要发现

  • 溶媒处理动物暗条件下阳离子通道活性增加。
  • Emixustat处理降低阳离子通道活性,其活性与光照条件下溶媒处理对照相当。
  • 溶媒处理动物视网膜从光漂白恢复时最低氧张力下降,提示氧消耗增加。
  • Emixustat处理阻止光漂白后氧压力下降。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: In the dark, photoreceptor outer segments contain high levels of cyclic guanosine 3'-5' monophosphate (cGMP), which binds to ion channels, holding them open and allowing an influx of cations. Ion pumping activity, which balances cation influx, uses considerable amounts of adenosine triphosphate (ATP) and oxygen. Light reduces cation influx and thereby lowers metabolic demand. Blood vessels are compromised in the diabetic retina and may not be able to meet the higher metabolic demand in darkness. Emixustat is a visual cycle modulator (VCM) that reduces chromophore levels and, therefore, may mimic light conditions. We evaluated the effect of emixustat on oxygen consumption and cation influx in dark conditions. METHODS: Cation influx was measured in rats using Mn2+-magnetic resonance imaging (MEMRI). Retinal oxygen profiles were recorded to evaluate oxygen consumption. In the MEMRI protocol, animals were treated with either emixustat or vehicle. In the oxygen protocol, animals were untreated or treated with emixustat. RESULTS: In vehicle-treated animals, cation channel activity increased in the dark. Emixustat treatment reduced cation channel activity; activity was comparable to vehicle-treated controls in light conditions. In vehicle-treated animals, minimum retinal oxygen tension decreased as the retina recovered from a photobleach, indicating that more oxygen was being consumed. Emixustat treatment prevented the decrease in oxygen pressure after photobleach. CONCLUSIONS: Emixustat reduced the cation influx and retinal oxygen consumption associated with dark conditions. VCMs are a promising potential treatment for ischemic retinal neovascularization, such as that in diabetic retinopathy.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Kubota R, Calkins DJ, Henry SH, et al. Emixustat Reduces Metabolic Demand of Dark Activity in the Retina. Invest Ophthalmol Vis Sci. 2019. PMID: 31770432. doi:10.1167/iovs.19-28194

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。